The method to surmise the prognosis of leukemia patients by analyzing the function of Notch protein

分析Notch蛋白功能推测白血病患者预后的方法

基本信息

  • 批准号:
    16590446
  • 负责人:
  • 金额:
    $ 1.22万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2004
  • 资助国家:
    日本
  • 起止时间:
    2004 至 2005
  • 项目状态:
    已结题

项目摘要

Notch signaling regulates the self-renewal and differentiation of hematopoietic progenitors. Since acute myeloblastic leukemia (AML) originates from dysregulated hematopoietic progenitors, the Notch system may be involved in the abnormal growth. We previously reported that AML cells express Notch proteins. In this study, we examined the effects of Notch ligands on the growth and differentiation of primary AML cells. AML cells were cultured in wells coated with the ligands or control IgG. The short-term growth, self-renewal capacity and differentiation were evaluated. The ligand stimulation caused three types of response in the short-term growth, namely, promotion, suppression or no significant effect. The self-renewal capacity was suppressed or not significantly affected by the ligands. The ligand stimulation altered blast cells into macrophage-like cells in some samples. Thus, Notch activation caused by the ligand stimulation had diverse effects. The relationship between responsiveness of the cells and prognosis of the patients could not be clarified yet.Effects of Notch activation on retinoic acid (RA)-induced differentiation and apoptosis were investigated. Acute promyelocytic leukemia (APL) cells undergo neutrophilic differentiation and apoptosis by RA. Notch activation induced by the Notch ligands made part of RA-treated NB4 cells monocyte-like shaped and reduced the apoptosis. The ligands suppressed the RA-induced cleavage of caspase-8 and PARP, which may be a possible mechanism through which the ligands suppress the RA-induced apoptosis.The effect of the Notch ligands on drug-sensitivity of leukemia cells was examined. The drug-induced growth suppression was slightly reduced by the ligand stimulation in some cells. The ligand-coated culture-plates are more similar to the microenvironment in human bone marrow than ordinary plates. We will further examine the clinical usefulness of the drug-sensitivity test using the ligand-coated plates.
Notch信号调节造血祖细胞的自我更新和分化。由于急性髓母细胞白血病(AML)起源于造血祖细胞失调,Notch系统可能参与了其异常生长。我们之前报道过AML细胞表达Notch蛋白。在这项研究中,我们研究了Notch配体对原代AML细胞生长和分化的影响。AML细胞在涂有配体或对照IgG的孔中培养。对其短期生长、自我更新能力和分化进行了评价。配体刺激在短期生长中引起三种类型的反应,即促进、抑制或无显著作用。这些配体抑制或不显著影响细胞的自我更新能力。在一些样品中,配体刺激使原始细胞转变为巨噬细胞样细胞。因此,配体刺激引起的Notch激活具有多种作用。细胞的反应性与患者预后之间的关系尚不清楚。研究了Notch激活对维甲酸(RA)诱导的细胞分化和细胞凋亡的影响。RA诱导急性早幼粒细胞白血病(APL)细胞嗜中性分化和凋亡。Notch配体诱导的Notch激活使部分ra处理的NB4细胞呈单核细胞样形状,减少了细胞凋亡。这些配体抑制了ra诱导的caspase-8和PARP的裂解,这可能是其抑制ra诱导的细胞凋亡的机制之一。观察Notch配体对白血病细胞药物敏感性的影响。在某些细胞中,配体刺激可轻微减轻药物诱导的生长抑制作用。配体包被培养板比普通培养板更接近人骨髓微环境。我们将进一步研究使用配体包被板进行药物敏感性试验的临床用途。

项目成果

期刊论文数量(34)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Effect of Notch ligands on in vitro sensitivity to chemotherapeutic drugs in leukemia and lymphoma cells
Notch配体对白血病和淋巴瘤细胞体外化疗药物敏感性的影响
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kogoshi H;Tohda S;Fu L;Nara N
  • 通讯作者:
    Nara N
Cellular analysis of growth suppression induced by the Notch ligands, Delta-1 and Jagged-1 in two myeloid leukemia cell lines
Notch 配体 Delta-1 和 Jagged-1 在两种髓系白血病细胞系中诱导生长抑制的细胞分析
The Notch ligand, Delta-1, alters retinoic acid (RA)-induced neutrophilic differentiation into monocytic and reduces RA-induced apoptosis in NB4 cells
  • DOI:
    10.1016/j.leukres.2004.05.020
  • 发表时间:
    2005-02-01
  • 期刊:
  • 影响因子:
    2.7
  • 作者:
    Murata-Ohsawa, M;Tohda, S;Nara, N
  • 通讯作者:
    Nara, N
Cellular analysis of growth suppression induced by the Notch ligands, Delta-1 and Jagged-1 in two myeloblastic leukemia cell lines.
在两种成粒细胞白血病细胞系中,Notch 配体 Delta-1 和 Jagged-1 诱导的生长抑制的细胞分析。
Delta-1, partially inhibits GM-CSF-induced differentiation and apoptosis along with reducing the cleavage of PARP in U937 cells.
Delta-1 部分抑制 GM-CSF 诱导的分化和细胞凋亡,同时减少 U937 细胞中 PARP 的裂解。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TOHDA Shuji其他文献

TOHDA Shuji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TOHDA Shuji', 18)}}的其他基金

Development of molecular targeted drug sensitivity tests that integrate gene panel testing and signaling protein analysis for leukemia
开发整合白血病基因组测试和信号蛋白分析的分子靶向药物敏感性测试
  • 批准号:
    20K07780
  • 财政年份:
    2020
  • 资助金额:
    $ 1.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Tests for self-renewal signals of acute leukemia stem cells and prediction of the effects of molecular-targeted drugs for the signals
急性白血病干细胞自我更新信号的检测及分子靶向药物对该信号影响的预测
  • 批准号:
    26460669
  • 财政年份:
    2014
  • 资助金额:
    $ 1.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Role of Notch in the pathophysiology of leukemia stem cells and drug sensitivity tests for Notch inhibitors
Notch在白血病干细胞病理生理学中的作用及Notch抑制剂的药敏试验
  • 批准号:
    20590557
  • 财政年份:
    2008
  • 资助金额:
    $ 1.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of the method to surmise the prognosis of acute myeloblastic leukemia patients by analyzing the expression of Notch protein
建立通过分析Notch蛋白表达来推测急性髓细胞白血病患者预后的方法
  • 批准号:
    13672415
  • 财政年份:
    2001
  • 资助金额:
    $ 1.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of the method to infer the responsiveness of acute myeloblastic leukemia cells for G-CSF
开发推断急性髓细胞白血病细胞对 G-CSF 反应性的方法
  • 批准号:
    10672171
  • 财政年份:
    1998
  • 资助金额:
    $ 1.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

空气颗粒物通过调控白血病抑制因子参与影响IgA肾病进展的作用与机制研究
  • 批准号:
    82370711
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
ELL在前列腺癌发生中的负性作用机制及其临床意义
  • 批准号:
    81101948
  • 批准年份:
    2011
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
PBX蛋白促肿瘤转移及VCP表达的调节作用研究
  • 批准号:
    30801382
  • 批准年份:
    2008
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
肿瘤DNA低甲基化发生分子机理及其对白血病发病重要性的研究
  • 批准号:
    30872933
  • 批准年份:
    2008
  • 资助金额:
    36.0 万元
  • 项目类别:
    面上项目
一个新型抗癌化合物对急性骨髓性白血病细胞Sin3A复合体的作用
  • 批准号:
    30672422
  • 批准年份:
    2006
  • 资助金额:
    30.0 万元
  • 项目类别:
    面上项目
人白血病干细胞与耐药性的关系研究
  • 批准号:
    30572203
  • 批准年份:
    2005
  • 资助金额:
    20.0 万元
  • 项目类别:
    面上项目

相似海外基金

Innovation of the novel therapeutic strategies against p53 mutated acute myeloid leukemia.
p53突变急性髓系白血病新治疗策略的创新。
  • 批准号:
    23K07824
  • 财政年份:
    2023
  • 资助金额:
    $ 1.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 1.22万
  • 项目类别:
    Operating Grants
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
  • 批准号:
    480030
  • 财政年份:
    2023
  • 资助金额:
    $ 1.22万
  • 项目类别:
    Operating Grants
Examining the multilevel factors on quality of end-of-life care among cancer patients in Puerto Rico
检查影响波多黎各癌症患者临终关怀质量的多层次因素
  • 批准号:
    10557584
  • 财政年份:
    2023
  • 资助金额:
    $ 1.22万
  • 项目类别:
Targeting Menin in Acute Leukemia with Upregulated HOX Genes
通过上调 HOX 基因靶向急性白血病中的 Menin
  • 批准号:
    10655162
  • 财政年份:
    2023
  • 资助金额:
    $ 1.22万
  • 项目类别:
Target the Dusp1 in Jak2 dependent myeloproliferative neoplasm (MPN) for curative treatment
针对 Jak2 依赖性骨髓增生性肿瘤 (MPN) 中的 Dusp1 进行治愈性治疗
  • 批准号:
    10655109
  • 财政年份:
    2023
  • 资助金额:
    $ 1.22万
  • 项目类别:
Targeting PLK1 in RAS mutant chronic myelomonocytic leukemia
RAS 突变型慢性粒单核细胞白血病中的靶向 PLK1
  • 批准号:
    10656778
  • 财政年份:
    2023
  • 资助金额:
    $ 1.22万
  • 项目类别:
Cancer-based discovery of novel mechanisms of chromatin control
基于癌症的染色质控制新机制的发现
  • 批准号:
    10660680
  • 财政年份:
    2023
  • 资助金额:
    $ 1.22万
  • 项目类别:
Regulation and function of aged hematopoietic stem cell (HSC) niche
衰老造血干细胞(HSC)生态位的调节和功能
  • 批准号:
    10723396
  • 财政年份:
    2023
  • 资助金额:
    $ 1.22万
  • 项目类别:
Deep-UV Microscopy for Real-Time Adequacy Analysis of Bone Marrow Aspirates
用于骨髓抽吸物实时充分性分析的深紫外显微镜
  • 批准号:
    10761397
  • 财政年份:
    2023
  • 资助金额:
    $ 1.22万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了